Stockscreener 앱 받기
0.6651
5.91%
0.0371
시간 외 거래:
.66
-0.0051
-0.77%
전일 마감가:
$0.628
열려 있는:
$0.6
하루 거래량:
2.10M
Relative Volume:
0.43
시가총액:
$20.09M
수익:
-
순이익/손실:
$-29.77M
주가수익비율:
-0.0435
EPS:
-15.2954
순현금흐름:
$-24.23M
1주 성능:
+17.30%
1개월 성능:
+104.96%
6개월 성능:
-55.95%
1년 성능:
-70.70%
1일 변동 폭
$0.592
$0.6899
1주일 범위
$0.5327
$0.75
52주 변동 폭
$0.25
$3.6499
Moleculin Biotech Inc Stock (MBRX) Company Profile
명칭
Moleculin Biotech Inc
전화
713-300-5160
주소
5300 MEMORIAL DRIVE, HOUSTON, TX
MBRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBRX
Moleculin Biotech Inc
|
0.6651 | 18.97M | 0 | -29.77M | -24.23M | -15.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-09 | 재개 | H.C. Wainwright | Buy |
| 2025-02-12 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Moleculin Biotech Inc 주식(MBRX)의 최신 뉴스
Moleculin receives notice of intent to grant new European patent for Annamycin - MSN
Moleculin Biotech Releases Corporate Presentation Update - TipRanks
Moleculin Biotech Inc. Ranks High in Smart Money TrackerROI Driven Equity Selection With Safety Emphasized - metal.it
What catalysts could drive Moleculin Biotech Inc. stock higher in 2025Post Market Watchlist For Every Investor - jammulinksnews.com
How strong is Moleculin Biotech Inc. company’s balance sheetBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com
What Caused the Sharp Drop in Moleculin Biotech (MBRX.O)? - AInvest
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin - GlobeNewswire
What is Moleculin Biotech Inc. company’s growth strategyFinancial News Tips For Beginners - jammulinksnews.com
Will Moleculin Biotech Inc. Stock Benefit from AI and Green Energy TrendsAccurate Buy Point for Momentum Stocks Detected - metal.it
Moleculin receives European patent notice for cancer drug Annamycin By Investing.com - Investing.com Nigeria
Moleculin receives European patent notice for cancer drug Annamycin - Investing.com
Moleculin Biotech Secures European Patent for Annamycin - TipRanks
Moleculin Biotech, Inc. Receives Notice of Intent to Grant European Patent for Annamycin, Strengthening Market Position in Oncology - Quiver Quantitative
Breakthrough Cancer Drug Patent: Moleculin's Non-Cardiotoxic Treatment Gains EU Protection Until 2040 - Stock Titan
Why Did Moleculin Biotech Inc. (MBRX) Soar 10.08%? - AInvest
Statistical indicators supporting Moleculin Biotech Inc.’s strengthIntraday Trend Analysis for Fast Gains Released - metal.it
Why Did Moleculin Biotech Inc. (MBRX) Soar 11.82%? - AInvest
why MBRX is up afterhours - AInvest
Why Moleculin Biotech Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
What are analysts’ price targets for Moleculin Biotech Inc. in the next 12 monthsConsistently exceptional gains - jammulinksnews.com
When is Moleculin Biotech Inc. stock expected to show significant growthAchieve breakthrough gains with smart trades - jammulinksnews.com
How volatile is Moleculin Biotech Inc. stock compared to the marketCapitalize on market momentum for maximum gains - jammulinksnews.com
What makes Moleculin Biotech Inc. stock price move sharplyGet exclusive market analysis for investors - jammulinksnews.com
Is it the right time to buy Moleculin Biotech Inc. stockExplosive capital gains - jammulinksnews.com
How does Moleculin Biotech Inc. compare to its industry peersOutstanding risk-reward balance - jammulinksnews.com
What are the latest earnings results for Moleculin Biotech Inc.Unlock rapid growth potential in your portfolio - jammulinksnews.com
whats better mbrx or pstv - AInvest
Is Moleculin Biotech Inc. a good long term investmentMassive wealth growth - PrintWeekIndia
How high can Moleculin Biotech Inc. stock price go in 2025High-margin investment plays - jammulinksnews.com
Moleculin Biotech Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - PrintWeekIndia
What drives Moleculin Biotech Inc. stock priceUnprecedented market success - PrintWeekIndia
What analysts say about Moleculin Biotech Inc. stockFree Risk Assessment Services - jammulinksnews.com
Moleculin Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire
Moleculin Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times
Exclusive: Moleculin CEO Shares Vision Behind Revolutionary Cancer Drug Pipeline in New Investor Presentation - Stock Titan
Moleculin Biotech Gains Approval for Phase 2B/3 AML Study - MSN
Moleculin Biotech Inc (MBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Moleculin Biotech Inc 주식 (MBRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KLEMP WALTER V | CEO and President |
Jun 23 '25 |
Buy |
0.37 |
675,675 |
250,000 |
743,607 |
0.93%
0.15%
자본화:
|
볼륨(24시간):